Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV Retinitis Retreatment Trial
NCT00000766Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Sep 1995
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of foscarnet sodium, ganciclovir in cytomegalovirus retinitis, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
foscarnet sodiumganciclovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00000766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000766.